Breaking News

NEW YORK, June 1 - Investigating a gene's function, scientists agree, requires a physical copy of that gene's DNA. Sounds simple enough.

NEW YORK, June 1 - The number of new funding deals continued to drop in May as the IPO market continued to weaken, venture capitalists remained weary, and private placements waned, a report released Friday by Facts Online said.

NEW YORK, May 31 - Venture capital firms RHO Ventures and Forward Ventures have raised new funds worth $435 and $256 million, respectively, for investments in information technology and life science companies, the firms said Thursday. 

NEW YORK, May 31 - Aventis Pharma and chemical microarray developer Graffinity Pharmaceutical Design have signed a collaboration to identify leads for Aventis' drug targets, the two companies said Thursday.  Financial details

NEW YORK, May 31 – Swedish proteomics companies Gyros and Affibody have begun a strategic alliance to jointly develop a microfluidics-based protein microarray on a compact-disk format, the companies said Thursday. The array, wh

NEW YORK, May 31 - Venture capital firms RHO Ventures and Forward Ventures have raised new funds worth $435 and $256 million, respectively, for investments in information technology and life science companies, the firms said Thursday.  

This story has been updated from a previous version. NEW YORK, May 31 – Roche said Thursday it would appeal the European Patent Office’s decision to revoke Roche’s patent for a number of enzymes, including Taq DNA polymerase, a staple in conducting PCR and gene sequencing.

NEW YORK, May 31 – Motorola has decided to abandon its previously announced plans to exclusively license Molecular Staging’s rolling circle amplification technology for use in its diagnostic nucleic acid bioarrays, a spokeswoman for Molecular Staging said Thursday.

NEW YORK, May 31 – ViaLactia Biosciences of Auckland, New Zealand and Orion Genomics of St. Louis, Mo., said Thursday they had agreed to team up to develop improved species of forage plants as well as the technologies for agricultural genomics.

NEW YORK, May 31 - Sangamo Biosciences's acquisition of Gendaq will allow the company to corner the market on zinc finger protein technology as well as to stave off any potential patent disputes, company executives said Thursday.

NEW YORK, May 30 – RheoGene, a privately held gene expression company based in Charlottesville, Va., announced Wednesday that it had appointed several genomics industry heavyweights to its scientific advisory board.

NEW YORK, May 30 - Sangamo Biosciences said Wednesday it has obtained the option to acquire privately-held Gendaq in a stock-for-stock deal worth $39.7 million. Sangamo, which is currently completing due diligence, ha

NEW YORK, May 30 – Incyte Genomics and Iconix Pharmaceuticals announced on Wednesday a collaboration to develop and commercialize the next-generation of Iconix’s ChemExpress chemogenomic platform. Incyte will exclusively market and sell ChemExpress, according to the companies.

NEW YORK, May 30 – LabBook said Wednesday that it had signed an agreement to provide its XML browser to Bristol-Myers Squibb. Under the terms of the deal, LabBook will customize its Genomic XML Browser to allow Bristol-Myers Squibb researchers to access

NEW YORK, May 30 - Blueprint Worldwide, a new not-for-profit organization established with support from IBM, MDS Proteomics, and the Canadian government, has taken over the administration of BIND, a free database of protein sequence and interaction data, IBM and MDS

NEW YORK, May 29 – HTS Biosystems announced Tuesday plans to establish an office in Yokohama, Japan in its effort to grow its proteomics business in the Asian market.

NEW YORK, May 29 – Molecular Staging of New Haven, Conn., announced Tuesday a handful of executive-level appointments, several of whom came from the leading companies in the genomics sector.

CHICAGO, May 29 – Micromass and Bio-Rad Laboratories have entered a deal to sell their jointly developed proteomics platform to the European Molecular Biology Laboratory in Heidelberg, Germany, a Micromass spokesman said Tuesday.

NEW YORK, May 29 – Over the past six months, with genomics companies scrambling over themselves to stake out a piece of the profits from drug discovery, it shouldn’t be too much of a surprise that Sequenom followed suit. But Sequenom’s

This story has been updated from a previous version. NEW YORK, May 29 - Sequenom has agreed to acquire Gemini Genomics in a stock-for-stock deal valued at $238 million, the companies said Tuesday.   

NEW YORK, May 29 – PerkinElmer and MDS Sciex announced an expanded partnership to develop Time-of-Flight-based mass spectrometry systems, the companies announced on Tuesday. The joint venture will focus on development of proteomics tools and high-throughput protein processing.

NEW YORK, May 29 – AlphaGene said Tuesday it had appointed Robert Brown, a neurology professor at Harvard Medical School, as a member of its scientific advisory board.

NEW YORK, May 28 - In observance of Memorial Day in the United States, GenomeWeb is closed and will not post any stories on Monday.

NEW YORK, May 25 – The state of Virginia has pledged $7 million to support genomics and bioinformatics initiatives at the state’s research universities.  Virginia Governor Jim Gilmore announced the grants Thursday as part

This story has been updated from a previous version. NEW YORK, May 25 - Isis Pharmaceuticals and Hybridon said Friday they had penned several cross-licensing agreements for antisense technologies, in a deal valu

Pages

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.